What PharmaResearch Co., Ltd.'s (KOSDAQ:214450) 32% Share Price Gain Is Not Telling You
Dec 19
Have your own idea? Try our Stock Screener
South Korean (KOSPI) Biotech Industry Analysis
UpdatedDec 20, 2024
DataAggregated Company Financials
Companies118
- 7D0.1%
- 3M-7.3%
- 1Y16.9%
- YTD1.4%
The Biotech industry is up 4.6% in the last week, with Celltrion up 4.1%. In the same time, ALTEOGEN was down 8.3%. This means that the industry has gained 22% over the past year. As for the next few years, earnings are expected to grow by 79% per annum.
Industry Valuation and Performance
Has the South Korean Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 20 Dec 2024 | ₩91.7t | ₩10.5t | -₩1,005,204,065,171.00 | 23.4x | -91.3x | 8.7x |
| Sun, 17 Nov 2024 | ₩92.3t | ₩10.3t | -₩697,979,635,797.00 | 25.1x | -132.3x | 8.9x |
| Tue, 15 Oct 2024 | ₩98.5t | ₩10.3t | -₩653,791,712,887.00 | 26.2x | -150.7x | 9.5x |
| Thu, 12 Sep 2024 | ₩89.6t | ₩10.3t | -₩663,870,338,267.00 | 24x | -134.9x | 8.7x |
| Sat, 10 Aug 2024 | ₩93.0t | ₩9.9t | -₩651,620,427,048.00 | 24.3x | -142.8x | 9.4x |
| Mon, 08 Jul 2024 | ₩85.9t | ₩9.9t | -₩651,620,427,048.00 | 22x | -131.9x | 8.7x |
| Wed, 05 Jun 2024 | ₩83.4t | ₩9.9t | -₩649,884,237,928.00 | 21.3x | -128.4x | 8.5x |
| Fri, 03 May 2024 | ₩82.2t | ₩9.6t | -₩574,854,220,678.00 | 22.3x | -143x | 8.6x |
| Sun, 31 Mar 2024 | ₩84.5t | ₩9.6t | -₩664,593,466,350.00 | 19.6x | -127.2x | 8.8x |
| Tue, 27 Feb 2024 | ₩78.9t | ₩9.7t | -₩534,696,541,747.00 | 63.3x | -147.6x | 8.1x |
| Thu, 25 Jan 2024 | ₩73.2t | ₩9.7t | -₩537,261,689,777.00 | 63x | -136.3x | 7.5x |
| Sat, 23 Dec 2023 | ₩63.9t | ₩10.1t | -₩324,942,076,247.00 | 28.5x | -196.7x | 6.3x |
| Mon, 20 Nov 2023 | ₩57.8t | ₩10.2t | -₩249,280,435,819.00 | 27x | -231.9x | 5.7x |
| Wed, 18 Oct 2023 | ₩54.7t | ₩10.2t | -₩239,053,318,689.00 | 28x | -229x | 5.4x |
| Fri, 15 Sep 2023 | ₩59.3t | ₩10.2t | -₩339,708,651,659.00 | 31.7x | -174.6x | 5.8x |
| Sun, 13 Aug 2023 | ₩60.9t | ₩10.3t | -₩166,187,036,659.00 | 31x | -366.3x | 5.9x |
| Tue, 11 Jul 2023 | ₩54.6t | ₩10.3t | -₩151,534,704,579.00 | 26.2x | -360.4x | 5.3x |
| Thu, 08 Jun 2023 | ₩63.0t | ₩10.3t | -₩151,338,675,579.00 | 30.1x | -416x | 6.1x |
| Sat, 06 May 2023 | ₩62.8t | ₩11.0t | ₩317.9b | 24.8x | 197.4x | 5.7x |
| Mon, 03 Apr 2023 | ₩57.4t | ₩10.9t | ₩319.1b | 23.6x | 180x | 5.2x |
| Wed, 01 Mar 2023 | ₩56.6t | ₩11.3t | ₩968.6b | 24.3x | 58.5x | 5x |
| Fri, 27 Jan 2023 | ₩59.5t | ₩11.3t | ₩970.8b | 24.4x | 61.3x | 5.3x |
| Sun, 25 Dec 2022 | ₩60.2t | ₩10.8t | ₩213.8b | 25.1x | 281.4x | 5.6x |
| Tue, 22 Nov 2022 | ₩61.5t | ₩11.1t | ₩369.1b | 19.8x | 166.7x | 5.6x |
| Thu, 20 Oct 2022 | ₩57.7t | ₩10.8t | ₩348.0b | 20.1x | 165.7x | 5.3x |
| Sat, 17 Sep 2022 | ₩61.8t | ₩10.8t | ₩495.4b | 23x | 124.8x | 5.7x |
| Mon, 15 Aug 2022 | ₩74.4t | ₩10.7t | ₩597.2b | 26.8x | 124.5x | 7x |
| Wed, 13 Jul 2022 | ₩71.3t | ₩10.7t | ₩597.6b | 25x | 119.3x | 6.7x |
| Fri, 10 Jun 2022 | ₩68.2t | ₩10.6t | ₩626.4b | 27.5x | 108.8x | 6.4x |
| Sun, 08 May 2022 | ₩68.3t | ₩10.0t | ₩866.3b | 25.7x | 78.8x | 6.8x |
| Tue, 05 Apr 2022 | ₩75.5t | ₩10.0t | ₩898.1b | 28.3x | 84.1x | 7.6x |
| Thu, 03 Mar 2022 | ₩71.5t | ₩9.4t | ₩769.1b | 33.6x | 93x | 7.6x |
| Sat, 29 Jan 2022 | ₩72.4t | ₩9.4t | ₩787.4b | 31.6x | 91.9x | 7.7x |
| Mon, 27 Dec 2021 | ₩91.7t | ₩9.4t | ₩787.4b | 39.3x | 116.5x | 9.8x |
Price to Earnings Ratio
116.5x
Current Industry PE
- Investors are optimistic on the South Korean Biotechs industry, and appear confident in long term growth rates.
- The 3-year average PS ratio of 6.9x is lower than the industry's current PS ratio of 11.1x.
Past Earnings Growth
- Total earnings for the Biotechs industry have declined over the last three years, with the industry now making a loss overall.
- Revenues have also declined 3.3% per year, which is driving profits down.
Industry Trends
Which industries have driven the changes within the South Korean Healthcare industry?
| KR Market | -1.64% | |
| Healthcare | 0.13% | |
| Biotech | 0.14% | |
| Biotech | 0.14% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| A214450 PharmaResearch | ₩258.50k | 11.7% +₩280.5b | 135.6% | PE30.3x | |
| A290650 L&C BIOLTD | ₩22.40k | 18.0% +₩77.6b | -21.8% | PS7.3x | |
| A372320 Curocell | ₩30.40k | 20.2% +₩72.0b | -7.5% | n/a | |
| A005690 Pharmicell | ₩8.35k | 15.8% +₩68.4b | 45.2% | n/a | |
| A115450 HLB TherapeuticsLtd | ₩10.67k | 7.7% +₩60.7b | 157.4% | PS15.4x |
